255 related articles for article (PubMed ID: 22939038)
1. Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival.
Gotsman I; Keren A; Lotan C; Zwas DR
J Card Fail; 2012 Sep; 18(9):694-701. PubMed ID: 22939038
[TBL] [Abstract][Full Text] [Related]
2. Uric acid, allopurinol therapy, and mortality in patients with acute heart failure--results of the Acute HEart FAilure Database registry.
Málek F; Ošťádal P; Pařenica J; Jarkovský J; Vítovec J; Widimský P; Linhart A; Fedorco M; Coufal Z; Miklík R; Krűger A; Vondraková D; Špinar J
J Crit Care; 2012 Dec; 27(6):737.e11-24. PubMed ID: 22699032
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry.
Baldasseroni S; Urso R; Maggioni AP; Orso F; Fabbri G; Marchionni N; Tavazzi L;
Nutr Metab Cardiovasc Dis; 2012 May; 22(5):442-8. PubMed ID: 21193292
[TBL] [Abstract][Full Text] [Related]
4. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition.
Harzand A; Tamariz L; Hare JM
Congest Heart Fail; 2012; 18(3):179-82. PubMed ID: 22587748
[TBL] [Abstract][Full Text] [Related]
5. Hyperuricemia predicts adverse outcomes in patients with heart failure.
Hamaguchi S; Furumoto T; Tsuchihashi-Makaya M; Goto K; Goto D; Yokota T; Kinugawa S; Yokoshiki H; Takeshita A; Tsutsui H;
Int J Cardiol; 2011 Sep; 151(2):143-7. PubMed ID: 20542341
[TBL] [Abstract][Full Text] [Related]
6. Hyperuricemia in acute heart failure. More than a simple spectator?
Alimonda AL; Núñez J; Núñez E; Husser O; Sanchis J; Bodí V; Miñana G; Robles R; Mainar L; Merlos P; Darmofal H; Llácer A
Eur J Intern Med; 2009 Jan; 20(1):74-9. PubMed ID: 19237097
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of electrocardiographic frontal QRS-T angle to predict increased morbidity and mortality in patients with chronic heart failure.
Gotsman I; Keren A; Hellman Y; Banker J; Lotan C; Zwas DR
Am J Cardiol; 2013 May; 111(10):1452-9. PubMed ID: 23453457
[TBL] [Abstract][Full Text] [Related]
8. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.
Wang S; Shu Z; Tao Q; Yu C; Zhan S; Li L
Nephrology (Carlton); 2011 Nov; 16(8):767-76. PubMed ID: 21854506
[TBL] [Abstract][Full Text] [Related]
9. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of uric acid by glucose tolerance status and survival: the Rancho Bernardo Study.
Kramer CK; von Mühlen D; Jassal SK; Barrett-Connor E
J Intern Med; 2010 Jun; 267(6):561-6. PubMed ID: 20337857
[TBL] [Abstract][Full Text] [Related]
11. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
12. The effect of thyroid function on clinical outcome in patients with heart failure.
Chen S; Shauer A; Zwas DR; Lotan C; Keren A; Gotsman I
Eur J Heart Fail; 2014 Feb; 16(2):217-26. PubMed ID: 24464626
[TBL] [Abstract][Full Text] [Related]
13. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Kaya MG; Uyarel H; Akpek M; Kalay N; Ergelen M; Ayhan E; Isik T; Cicek G; Elcik D; Sahin O; Cosgun SM; Oguzhan A; Eren M; Gibson CM
Am J Cardiol; 2012 Feb; 109(4):486-91. PubMed ID: 22100027
[TBL] [Abstract][Full Text] [Related]
15. The independent association between serum uric acid and graft outcomes after kidney transplantation.
Haririan A; Nogueira JM; Zandi-Nejad K; Aiyer R; Hurley H; Cooper M; Klassen DK; Weir MR
Transplantation; 2010 Mar; 89(5):573-9. PubMed ID: 19997058
[TBL] [Abstract][Full Text] [Related]
16. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease.
Ndrepepa G; Braun S; King L; Cassese S; Tada T; Fusaro M; Hadamitzky M; Haase HU; Schömig A; Kastrati A
Clin Sci (Lond); 2013 Feb; 124(4):259-68. PubMed ID: 22974091
[TBL] [Abstract][Full Text] [Related]
18. Potentials of cystatin C and uric acid for predicting prognosis of heart failure.
Kim H; Yoon HJ; Park HS; Cho YK; Nam CW; Hur SH; Kim YN; Kim KB
Congest Heart Fail; 2013; 19(3):123-9. PubMed ID: 23241077
[TBL] [Abstract][Full Text] [Related]
19. Impaired fasting glucose: a predictor of reduced survival in patients with heart failure.
Gotsman I; Shauer A; Lotan C; Keren A
Eur J Heart Fail; 2014 Nov; 16(11):1190-8. PubMed ID: 25080892
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoprotein cholesterol levels and prognosis in advanced heart failure.
Mehra MR; Uber PA; Lavie CJ; Milani RV; Park MH; Ventura HO
J Heart Lung Transplant; 2009 Sep; 28(9):876-80. PubMed ID: 19716038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
